<Suppliers Price>

1,3-DIPROPYL-8-P-SULFOPHENYLXANTHINE

Names

[ CAS No. ]:
89073-57-4

[ Name ]:
1,3-DIPROPYL-8-P-SULFOPHENYLXANTHINE

[Synonym ]:
1,3-Dspx
4-(2,3,6,7-Tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-benzenesulfonic acid
Benzenesulfonic acid,4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)
DPSPX
PSPX
1,3-Dipropyl-8-(p-sulfophenyl)xanthine
4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)benzenesulfonic acid
MFCD00055080

Chemical & Physical Properties

[ Density]:
1.405g/cm3

[ Melting Point ]:
>300ºC

[ Molecular Formula ]:
C17H20N4O5S

[ Molecular Weight ]:
392.43000

[ Exact Mass ]:
392.11500

[ PSA ]:
135.43000

[ LogP ]:
2.70080

[ Index of Refraction ]:
1.607

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Safety Phrases ]:
S22-S24/25

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2933990090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.

Am. J. Physiol. Renal Physiol. 304(1) , F49-55, (2013)

In a previous study, we demonstrated that human proximal tubular epithelial cells obtained from a commercial source metabolized extracellular 2',3'-cAMP to 2'-AMP and 3'-AMP and extracellular 2'-AMP a...

Expression of the 2',3'-cAMP-adenosine pathway in astrocytes and microglia.

J. Neurochem. 118 , 979-987, (2011)

Many organs express the extracellular 3',5'-cAMP-adenosine pathway (conversion of extracellular 3',5'-cAMP to 5'-AMP and 5'-AMP to adenosine). Some organs release 2',3'-cAMP (isomer of 3',5'-cAMP) and...

Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant response.

J. Pharmacol. Exp. Ther. 292(3) , 929-38, (2000)

Recent studies have demonstrated that three membrane-permeant A(1) receptor antagonists reduced infarct size in a model of ischemia followed by brief reperfusion. However, it was not determined whethe...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.